Paper35864293
Propensity score matching analysis comparing radical prostatectomy and radiotherapy with androgen deprivation therapy in locally advanced prostate cancer.
Lu YC and 13 others. Sci Rep, 2022. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Propensity score matching analysis comparing radical prostatectomy and radiotherapy with androgen deprivation therapy in locally advanced prostate cancer. Papers, record 35864293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35864293
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Propensity score matching analysis comparing radical prostatectomy and radiotherapy with androgen deprivation therapy in locally advanced prostate cancer.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Prostatic Neoplasms | Major topic |
| Androgen Antagonists | |
| Androgens | |
| Humans | |
| Male | |
| Neoplasm Recurrence, Local | |
| Propensity Score | |
| Prostate-Specific Antigen | |
| Prostatectomy | |
| Retrospective Studies |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32591157 | Association between low prostate-specific antigen levels and greater disease progression in high-grade locally-advanced prostate cancer. | J Formos Med Assoc | 2021 | https://conductscience.org/library/papers/32591157 | PubMed |
| 2 | 31068988 | Epidemiology of Prostate Cancer. | World J Oncol | 2019 | https://conductscience.org/library/papers/31068988 | PubMed |
| 3 | 31375279 | Randomised Trial of Adjuvant Radiotherapy Following Radical Prostatectomy Versus Radical Prostatectomy Alone in Prostate Cancer Patients with Positive Margins or Extracapsular Extension. | Eur Urol | 2019 | https://conductscience.org/library/papers/31375279 | PubMed |
| 4 | 30585526 | SPCG-15: a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer. | Scand J Urol | 2018 | https://conductscience.org/library/papers/30585526 | PubMed |
| 5 | 29717358 | Survival after radical prostatectomy or radiotherapy for locally advanced (cT3) prostate cancer. | World J Urol | 2018 | https://conductscience.org/library/papers/29717358 | PubMed |
| 6 | 26181727 | Dose-Escalated Irradiation and Overall Survival in Men With Nonmetastatic Prostate Cancer. | JAMA Oncol | 2015 | https://conductscience.org/library/papers/26181727 | PubMed |
| 7 | 11176485 | Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database. | J Urol | 2001 | https://conductscience.org/library/papers/11176485 | PubMed |
| 8 | 33117669 | Application of Radiomics for the Prediction of Radiation-Induced Toxicity in the IMRT Era: Current State-of-the-Art. | Front Oncol | 2020 | https://conductscience.org/library/papers/33117669 | PubMed |
| 9 | 18172188 | Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610. | J Clin Oncol | 2008 | https://conductscience.org/library/papers/18172188 | PubMed |
| 10 | 30836166 | Dose Escalation for Prostate Adenocarcinoma: A Long-Term Update on the Outcomes of a Phase 3, Single Institution Randomized Clinical Trial. | Int J Radiat Oncol Biol Phys | 2019 | https://conductscience.org/library/papers/30836166 | PubMed |
| 11 | 28757301 | Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review. | Eur Urol | 2017 | https://conductscience.org/library/papers/28757301 | PubMed |
| 12 | 11422794 | Discrepancies between Gleason scores of needle biopsy and radical prostatectomy specimens. | Pathol Int | 2001 | https://conductscience.org/library/papers/11422794 | PubMed |
| 13 | 29543933 | Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial. | JAMA Oncol | 2018 | https://conductscience.org/library/papers/29543933 | PubMed |
| 14 | 23835712 | Challenges of guarantee-time bias. | J Clin Oncol | 2013 | https://conductscience.org/library/papers/23835712 | PubMed |
| 15 | 22934913 | 20-Year survival after radical prostatectomy as initial treatment for cT3 prostate cancer. | BJU Int | 2012 | https://conductscience.org/library/papers/22934913 | PubMed |
| 16 | 15821485 | Treatment of patients with high risk localized prostate cancer: results from cancer of the prostate strategic urological research endeavor (CaPSURE). | J Urol | 2005 | https://conductscience.org/library/papers/15821485 | PubMed |
| 17 | 26215604 | Accuracy of Magnetic Resonance Imaging for Local Staging of Prostate Cancer: A Diagnostic Meta-analysis. | Eur Urol | 2016 | https://conductscience.org/library/papers/26215604 | PubMed |
| 18 | 17698141 | The significance of positive surgical margin in areas of capsular incision in otherwise organ confined disease at radical prostatectomy. | J Urol | 2007 | https://conductscience.org/library/papers/17698141 | PubMed |
| 19 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
| 20 | 31718822 | Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized Trials. | Eur Urol | 2020 | https://conductscience.org/library/papers/31718822 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39516348 | Efficacy and safety of neoadjuvant chemohormonal therapy for high-risk prostate cancer treated with robot-assisted laparoscopic radical prostatectomy: a propensity score-matched analysis (the MSUG94 group). | Int Urol Nephrol | 2025 | https://conductscience.org/library/papers/39516348 | PubMed |
| 39337047 | Overall Survival and Cancer-Specific Mortality in Patients with Prostate Cancer Undergoing Definitive Therapies: A Narrative Review. | J Clin Med | 2024 | https://conductscience.org/library/papers/39337047 | PubMed |
| 39145084 | Combination approach using neoadjuvant therapy with radical prostatectomy for improving oncological outcomes of high-risk prostate cancer: a narrative review. | Transl Cancer Res | 2024 | https://conductscience.org/library/papers/39145084 | PubMed |
| 38784314 | Assessing the Efficacy and Long-Term Outcomes of Surgical Intervention Versus Radiotherapy: A Comprehensive Systematic Review and Meta-Analysis of Prostate Cancer Treatment Modalities. | Cureus | 2024 | https://conductscience.org/library/papers/38784314 | PubMed |
| 37740045 | Comparing pentafecta outcomes between nerve sparing and non nerve sparing robot-assisted radical prostatectomy in a propensity score-matched study. | Sci Rep | 2023 | https://conductscience.org/library/papers/37740045 | PubMed |
| 37240717 | Efficacy and Safety of Neoadjuvant Luteinizing Hormone-Releasing Hormone Antagonist and Tegafur-Uracil Chemohormonal Therapy for High-Risk Prostate Cancer. | Life (Basel) | 2023 | https://conductscience.org/library/papers/37240717 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD200 | 4345 | PubTator's text mining | https://conductscience.org/library/genes/4345 | NCBI Gene |
| KLK3 | 354 | PubTator's text mining | https://conductscience.org/library/genes/354 | NCBI Gene |
| NPEPPS | 9520 | PubTator's text mining | https://conductscience.org/library/genes/9520 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35864293
GET https://conductscience.org/api/papers/v1/35864293/references?page=2